Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of mogamulizumab in combination with
docetaxel in adult subjects with previously treated locally advanced or metastatic non-small
cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Kyowa Kirin Pharmaceutical Development, Inc. Kyowa Kirin, Inc.